Recent Updates
Recently added Catalysts
GNLX Positive Sentiment Score: 75/100

Genelux Corporation to Participate in Fireside Chat at BTIG’s Virtual Biotechnology Conference 2024

Tuesday, July 30, 2024 1 min read
Key Takeaway: Genelux Corporation is set to participate in a fireside chat at BTIG's Virtual Biotechnology Conference 2024. Thomas Zindrick, the company's President, CEO, and Chairman, will discuss various topics, including clinical-stage programs and recent announcements. This event is scheduled for August 6, 2024, at 12:00 p.m. ET, and will be led by Kaveri Pohlman, a BTIG Biotechnology Analyst.

Market Sentiment Analysis

POSITIVE FACTORS

  • Genelux is participating in a prominent virtual biotechnology conference.
  • The fireside chat will cover clinical-stage programs and upcoming milestones.
  • The engagement with a respected analyst may enhance visibility for Genelux.

Full Press Release Details

WESTLAKE VILLAGE, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced that Thomas Zindrick, President, CEO and Chairman, will discuss clinical-stage programs, recent announcements, and upcoming milestones in a fireside chat at BTIG’s Virtual Biotechnology Conference 2024.
The conversation with Kaveri Pohlman, PhD, Director and BTIG Biotechnology Analyst, is scheduled to begin at 12:00 p.m. ET on Tuesday, August 6, 2024.
About Genelux Corporation
Investor and Media Contacts
Allele Communications, LLC
genelux@allelecomms.com
Source: Genelux Corporation

Tags

Frequently Asked Questions

Who will discuss Genelux's clinical-stage programs?

Thomas Zindrick, the President, CEO, and Chairman of Genelux will lead the discussion.

When is the BTIG virtual conference for Genelux?

The fireside chat is scheduled for August 6, 2024, at 12:00 p.m. ET.

Who is joining the discussion with Thomas Zindrick?

Kaveri Pohlman, PhD, a BTIG Biotechnology Analyst, will join him.

What topics will be covered in the fireside chat?

The discussion will cover clinical-stage programs and upcoming milestones.

Where can I find media contacts for Genelux?

Media inquiries can be directed to Allele Communications at genelux@allelecomms.com.

Tags: GNLX Viatris Investor Conferences Healthcare Genelux biotechnology immuno-oncology clinical-stage programs
Last updated: Jul 30, 2024